Literature DB >> 29666839

The structure of the nucleus in normal and neoplastic prostate cells: untangling the role of type 2 DNA topoisomerases.

William G Nelson1, Michael C Haffner1, Srinivasan Yegnasubramanian1.   

Abstract

Donald S. Coffey, a pioneer in the study of the structural basis of mammalian genome organization, was fascinated by DNA topoisomerases, chemo-mechanical enzymes that could catalyze changes in DNA structure. Work initiated in his laboratory and carried on with his influence and inspiration has led to the elucidation of specific roles for each of the two type 2 topoisomerases in DNA replication, RNA transcription, and androgen action in prostate cells. TOP2A principally acts in DNA synthesis elongation to prevent tangling of daughter DNA molecules during genome replication and mitotic segregation; TOP2B is required for androgen-stimulation of target gene transcription. DNA double-strand breaks inflicted by TOP2B upon androgen exposure appear responsible for the generation of TMPRSS2-ERG and other gene fusions, often found in complex chained rearrangements termed chromoplexy, in prostate cancer cells. TOP2B-mediated genome damage may also provide an avenue for improving prostate cancer treatment via timed androgen administration in conjunction with ionizing radiation, with TOP2-targeted drugs, or with DNA repair inhibitors.

Entities:  

Keywords:  DNA topoisomerases; normal prostate; prostate cancer; structure of the nucleus

Year:  2018        PMID: 29666839      PMCID: PMC5902729     

Source DB:  PubMed          Journal:  Am J Clin Exp Urol        ISSN: 2330-1910


  60 in total

Review 1.  Cancer as a disease of DNA organization and dynamic cell structure.

Authors:  K J Pienta; A W Partin; D S Coffey
Journal:  Cancer Res       Date:  1989-05-15       Impact factor: 12.701

Review 2.  Untangling the role of DNA topoisomerase II in mitotic chromosome structure and function.

Authors:  P E Warburton; W C Earnshaw
Journal:  Bioessays       Date:  1997-02       Impact factor: 4.345

3.  Reconstitution of mitotic chromatids with a minimum set of purified factors.

Authors:  Keishi Shintomi; Tatsuro S Takahashi; Tatsuya Hirano
Journal:  Nat Cell Biol       Date:  2015-06-15       Impact factor: 28.824

4.  Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites.

Authors:  P N Cockerill; W T Garrard
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

5.  The nuclear matrix of the prostate contains acceptor sites for androgen receptors.

Authors:  E R Barrack
Journal:  Endocrinology       Date:  1983-07       Impact factor: 4.736

6.  The ovalbumin gene is associated with the nuclear matrix of chicken oviduct cells.

Authors:  S I Robinson; B D Nelkin; B Vogelstein
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

7.  In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction.

Authors:  M Berrios; N Osheroff; P A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

8.  The association of transcriptionally active genes with the nuclear matrix of the chicken oviduct.

Authors:  S I Robinson; D Small; R Idzerda; G S McKnight; B Vogelstein
Journal:  Nucleic Acids Res       Date:  1983-08-11       Impact factor: 16.971

9.  Characterization of nuclear structures containing superhelical DNA.

Authors:  P R Cook; I A Brazell; E Jost
Journal:  J Cell Sci       Date:  1976-11       Impact factor: 5.285

10.  Preferential, cooperative binding of DNA topoisomerase II to scaffold-associated regions.

Authors:  Y Adachi; E Käs; U K Laemmli
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  1 in total

1.  AK-I-190, a New Catalytic Inhibitor of Topoisomerase II with Anti-Proliferative and Pro-Apoptotic Activity on Androgen-Negative Prostate Cancer Cells.

Authors:  Kyung-Hwa Jeon; Seojeong Park; Hae Jin Jang; Soo-Yeon Hwang; Aarajana Shrestha; Eung-Seok Lee; Youngjoo Kwon
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.